206 related articles for article (PubMed ID: 3082204)
1. Unilateral multinodular toxic goiter: scintiscan mimicking solitary toxic nodule.
DeRubertis FR; Geyer SJ
Am J Med Sci; 1986 Mar; 291(3):183-6. PubMed ID: 3082204
[TBL] [Abstract][Full Text] [Related]
2. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.
Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M
J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784
[TBL] [Abstract][Full Text] [Related]
3. Current management of the patient with autonomously functioning nodular goiter.
Thomas CG; Croom RD
Surg Clin North Am; 1987 Apr; 67(2):315-28. PubMed ID: 3551148
[TBL] [Abstract][Full Text] [Related]
4. Unilateral toxic multicystic goiter.
Kern PA; Robbins RJ
Arch Intern Med; 1983 Apr; 143(4):834-5. PubMed ID: 6838305
[TBL] [Abstract][Full Text] [Related]
5. Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland.
Kasagi K; Shimatsu A; Miyamoto S; Misaki T; Sakahara H; Konishi J
Thyroid; 1999 Aug; 9(8):791-6. PubMed ID: 10482372
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hemiagenesis with multinodular goiter: a case report and review of the literature.
Karabay N; Comlekci A; Canda MS; Bayraktar F; Degirmenci B
Endocr J; 2003 Aug; 50(4):409-13. PubMed ID: 14599114
[TBL] [Abstract][Full Text] [Related]
7. Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters.
Studer H; Hunziker HR; Ruchti C
Am J Med; 1978 Aug; 65(2):227-34. PubMed ID: 686008
[TBL] [Abstract][Full Text] [Related]
8. Recurrent transient thyrotoxicosis in multinodular goitre.
Arem R
Postgrad Med J; 1990 Jan; 66(771):54-6. PubMed ID: 2349169
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
Burch HB; Shakir F; Fitzsimmons TR; Jaques DP; Shriver CD
Thyroid; 1998 Oct; 8(10):871-80. PubMed ID: 9827653
[TBL] [Abstract][Full Text] [Related]
10. Low thyrotropin (TSH) levels in goiter. Relationship with scintigraphic findings and other biological parameters.
Talbot JN; Duron F; Piketty ML; Habert MO; Laforest MD; Milhaud G
Thyroidology; 1989 Apr; 1(1):39-44. PubMed ID: 2484906
[TBL] [Abstract][Full Text] [Related]
11. Standard dose 131I therapy for hyperthyroidism caused by autonomously functioning thyroid nodules.
Ng Tang Fui SC; Maisey MN
Clin Endocrinol (Oxf); 1979 Jan; 10(1):69-77. PubMed ID: 436306
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of conventional and echo colour Doppler sonography in the differential diagnosis of toxic multinodular goitres.
Boi F; Loy M; Piga M; Serra A; Atzeni F; Mariotti S
Eur J Endocrinol; 2000 Sep; 143(3):339-46. PubMed ID: 11022175
[TBL] [Abstract][Full Text] [Related]
13. Sequential presentation of a case of hyperthyroidism with autonomously functioning nodules and Graves' disease in the presence of IgG thyroid stimulators.
Smyth PP; Neylan D; McMullan NM; Smith DF; McKenna TJ
Acta Endocrinol (Copenh); 1988 Aug; 118(4):474-8. PubMed ID: 2899938
[TBL] [Abstract][Full Text] [Related]
14. [The TRH test in simple goiter].
Paleari F; Colombo MC; Rovelli F; Capra M
Minerva Med; 1982 Dec; 73(48):3417-23. PubMed ID: 6817236
[TBL] [Abstract][Full Text] [Related]
15. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
16. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter.
Tonacchera M; Vitti P; Agretti P; Giulianetti B; Mazzi B; Cavaliere R; Ceccarini G; Fiore E; Viacava P; Naccarato A; Pinchera A; Chiovato L
Thyroid; 1998 Jul; 8(7):559-64. PubMed ID: 9709907
[TBL] [Abstract][Full Text] [Related]
17. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
18. Thyroid suppression and stimulation testing: The place of scanning in the evaluation of nodular thyroid disease.
Hurley JR; Becker DV
Semin Nucl Med; 1981 Apr; 11(2):149-60. PubMed ID: 6894650
[TBL] [Abstract][Full Text] [Related]
19. Disappearance of a hyperfunctioning thyroid nodule following TSH stimulation.
Kammer H; Loveless MO
J Nucl Med; 1978 Oct; 19(10):1149-50. PubMed ID: 722327
[TBL] [Abstract][Full Text] [Related]
20. Evolution of autonomy in idiopathic non-toxic goiter, evaluated by regional suppressibility of 99mTc-uptake and TSH response to TRH.
Dige-Petersen H; Clemmensen OJ; Hummer L
Nuklearmedizin; 1976 Aug; 15(4):197-200. PubMed ID: 824625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
